Sodium phenylbutyrate
STUDY25060137
Phase 1 small_molecule active
Quick answer
Sodium phenylbutyrate for Combined D,L-2-hydroxyglutaric Aciduria is a Phase 1 program (small_molecule) at ZEVRA THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ZEVRA THERAPEUTICS, INC.
- Indication
- Combined D,L-2-hydroxyglutaric Aciduria
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active